| Patent application number | Description | Published |
|---|
| 20110071498 | FREE-STANDING BIODEGRADABLE PATCH - Methods and apparatus for a free-standing biodegradable patch suitable for medical applications, especially intravascular, minimally-invasive and intraoperative surgical applications are provided, wherein the patch comprises a free-standing film or device having a mixture of a solid fibrinogen component and a solid thrombin component that, when exposed to an aqueous environment, undergoes polymerization to form fibrin. In alternative embodiments the patch may comprise a solid fibrinogen component, with or without an inorganic calcium salt component. The patch may take a non-adherent form during delivery to a target location within a vessel or tissue, and thereafter may be activated to adhere to vessel wall or tissue, and may include a number of additives, including materials to improve the mechanical properties of the patch, or one or more therapeutic or contrast agents. | 03-24-2011 |
| 20110071499 | FREE-STANDING BIODEGRADABLE PATCH - Methods and apparatus for a free-standing biodegradable patch suitable for medical applications, especially intravascular, minimally-invasive and intraoperative surgical applications are provided, wherein the patch comprises a free-standing film or device having a mixture of a solid fibrinogen component and a solid thrombin component that, when exposed to an aqueous environment, undergoes polymerization to form fibrin. In alternative embodiments the patch may comprise a solid fibrinogen component, with or without an inorganic calcium salt component. The patch may take a non-adherent form during delivery to a target location within a vessel or tissue, and thereafter may be activated to adhere to vessel wall or tissue, and may include a number of additives, including materials to improve the mechanical properties of the patch, or one or more therapeutic or contrast agents. | 03-24-2011 |
| 20110196186 | METHODS AND APPARATUS EMPLOYING IONIZING RADIATION FOR TREATMENT OF CARDIAC ARRHYTHMIA - Method and apparatus are disclosed employing ionizing radiation. for forming lines of ablation or lesions in cardiac tissue to treat atrial fibrillation or other electrophysiological problems with the heart. The apparatus may include a catheter in which the radiation source is advanced hydraulically after the catheter is in place within the heart. Various fixation devices are also disclosed for fixing the location of the catheter within the heart. | 08-11-2011 |
| Patent application number | Description | Published |
|---|
| 20090010154 | Protection Scheme - A protection scheme for a metro optical network involves programming ingress nodes and egress nodes with a primary multicast label switched path (LSP) and a back-up LSP to provide one-to-one protection. The primary and back-up LSPs are configured prior to the occurrence of a network fault to allow the network to transmit multicast communication when the fault occurs. Particularly, multicast communications are sent on the primary LSP during normal operation. However, when a network fault occurs, the nodes also send a duplicate multicast communication over the back-up LSP. Configuring the primary and back-up LSPs prior to the fault occurring avoids the need for signalling to establish a working LSP after a fault occurs. | 01-08-2009 |
| 20100002578 | Resiliency Schemes in Communications Networks - A connection oriented communications network | 01-07-2010 |
| 20100085982 | Optimized Synchronization of Mac Address Tables in Network Interconnection Apparatuses - Network interconnection apparatus ( | 04-08-2010 |
| 20110103225 | BANDWIDTH SIGNALLING - A telecommunication network comprising a plurality of nodes including a content source ( | 05-05-2011 |
| 20110299551 | Method and Apparatus for Transferring Data Packets Between a First Network and a Second Network - There is provided method and apparatus for transferring data packets between a first network and a second network using a node arrangement. The node arrangement has at least two primary nodes connected to the second network. Each primary node is connected to the first network using a respective first port and to a secondary node coupled to the second network using respective second ports. The second ports are arranged into respective link aggregation groups. The primary nodes are connected by respective inter-node ports. The method comprises the step of determining a service identifier associated with a packet received at a said primary node from the first network. The method comprises the further step of switching the packet to the second network using the respective second ports or to the other primary node using the inter-node port dependent on a service identifier associated with said packet. | 12-08-2011 |
| 20120020207 | RE-ROUTING TRAFFICE IN A COMMUNICATIONS NETWORK - Method of re-routing traffic in a communications network ( | 01-26-2012 |
| 20120155283 | INTERWORKING FOR OAM INFORMATION EXCHANGE | 06-21-2012 |
| 20120188867 | RECOVERY OF TRAFFIC IN A CONNECTION-ORIENTED NETWORK - A connection-oriented network ( | 07-26-2012 |
| 20120287818 | MULTIPOINT-TO-MULTIPOINT SERVICE FOR A COMMUNICATIONS NETWORK - A multipoint-to-multipoint service is provided between a set of edge nodes of a communications network. The network comprises at least two sub-networks and an intermediate node at a boundary between sub-networks. For each pair of edge nodes comprising an edge node in a first of the sub-networks and an edge node in a second of the sub-networks, a multi-segment pseudowire connection is configured between the pair of edge nodes. The pseudowire connection passing via at least one intermediate node. At the intermediate node forwarding data is configured which specifies a forwarding relationship between pseudowire segments corresponding to the multi-segment pseudowire connections. A topology of Label Switched Paths carry the multi-segment pseudowires. Edge nodes within a sub-network can be connected with a mesh topology or a hub-and-spoke topology. | 11-15-2012 |
| 20130010813 | Method and Apparatus for Optimizing Packet Timing Transport - There is provided a method of optimizing timing packet transport in a network node, the method comprising using a locally available stable frequency reference at the network node to provide a pre-determined network node transit time for timing packets in at least one direction into or out of the network node. There is also provided a network node comprising a locally available stable frequency reference and circuitry adapted to apply a pre-determined network node transit time, L, to all timing packets transiting the network node in at least one direction into or out of a network node dependent on the locally available stable frequency reference. | 01-10-2013 |
| 20130021918 | FAULT MONITORING IN CONNECTION-ORIENTED NETWORKS - The invention relates to a method of fault monitoring in a fault monitoring entity of a network node of a network having at least a first connection-oriented network layer, having first protection measures associated therewith, and a second connection-oriented network layer, having second protection measures associated therewith. In a first step the service condition status of the first network layer is monitored using the first protection measures. In a second step the second network layer protection measures are determined for onward transmission within the second network layer depending on the service condition status of the first network layer. Since the network node is aware of the monitored status condition of both the first and second layers the protection mechanisms for the first network layer and the second network layer can be co-ordinated and the second network layer protection measure for onward transmission may be determined for optimum network fault protection operation. | 01-24-2013 |
| 20130039220 | CONFIGURATION OF SYNCHRONISATION NETWORK HAVING SYNCHRONIZATION TRAILS FOR TIME SYNC AND FREQUENCY SYNC - Configuring a node ( | 02-14-2013 |
| Patent application number | Description | Published |
|---|
| 20090130195 | PROSTATE CARCINOGENESIS PREDICTOR - A method of detecting prostate tumorigenesis in a subject, the method including the steps of (a) obtaining a sample from the prostate of the human subject, (b) detecting quantitatively or semi-quantitatively in the sample a level of expression for PKC-ι and (c) comparing the expression level in (b) to a level of expression in a normal control, wherein overexpression of PKC-ι, with respect to the control, indicates the presence of prostate cancer in the subject. The present invention is based upon the discovery that PKC-ι levels are elevated during prostate tumorigenesis. Furthermore, the proliferation rate of the tumor correlates with the level of PKC-ι. The invention also provides methods of treating prostate cancer by administering to the subject a compound that inhibits the expression of PKC-ι. The compound can be a small interfering RNA (siRNA) molecule. | 05-21-2009 |
| 20120294932 | Prostate Carcinogenesis Predictor - A method of detecting prostate tumorigenesis in a subject, the method including the steps of (a) obtaining a sample from the prostate of the human subject, (b) detecting quantitatively or semi-quantitatively in the sample a level of expression for PKC-ι and (c) comparing the expression level in (b) to a level of expression in a normal control, wherein overexpression of PKC-ι, with respect to the control, indicates the presence of prostate cancer in the subject. The present invention is based upon the discovery that PKC-ι levels are elevated during prostate tumorigenesis. Furthermore, the proliferation rate of the tumor correlates with the level of PKC-ι. The invention also provides methods of treating prostate cancer by administering to the subject a compound that inhibits the expression of PKC-ι. The compound can be a small interfering RNA (siRNA) molecule. | 11-22-2012 |
| Patent application number | Description | Published |
|---|
| 20090250626 | LIQUID SANITIZATION DEVICE - The present invention includes a liquid sanitization device including one or more light emitting diodes (LED) that emit electro-magnetic radiation primarily at two or more distinct wavelengths. These wavelengths should be less than about 300 nm, preferably between about 210 to about 300 nm. The radiation from the light emitting diode or diodes kills or interacts with the DNA or RNA of pathogenic organisms in the liquid to prevent the organisms from reproducing or harming desirable organisms. | 10-08-2009 |
| 20120021175 | POLYCRYSTALLINE ALUMINUM NITRIDE MATERIAL AND METHOD OF PRODUCTION THEREOF - Methods of preparing polycrystalline aluminum nitride materials that have high density, high purity, and favorable surface morphology are disclosed. The methods generally comprises pressing aluminum nitride powders to form a slug, sintering the slug to form a sintered, polycrystalline aluminum nitride boule, and optionally shaping the boule and/or polishing at least a portion of the boule to provide a finished substrate. The sintered, polycrystalline aluminum nitride materials beneficially are prepared without the use of any sintering aid or binder, and the formed materials exhibit excellent density, AlN purity, and surface morphology. | 01-26-2012 |
| 20120146023 | THERMAL EXPANSION ENGINEERING FOR POLYCRYSTALLINE ALUMINUM NITRIDE SINTERED BODIES - Disclosed are methods and materials useful in the preparation of semiconductor devices. In particular embodiments, disclosed are methods for engineering polycrystalline aluminum nitride substrates that are thermally matched to further materials that can be combined therewith. For example, the polycrystalline aluminum nitride substrates can be engineered to have a coefficient of thermal expansion (CTE) that is closely matched to the CTE of a semiconductor material and/or to a material that can be used as a growth substrate for a semiconductor material. The invention also encompasses devices incorporating such thermally engineered substrates and semiconductor materials grown using such thermally engineered substrates. The thermally engineered substrates are advantageous for overcoming problems caused by damage arising from CTE mismatch between component layers in semiconductor preparation methods and materials. | 06-14-2012 |
